BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
Get Our Industry eNewsletter FREE email:    
Biotech/Pharma - Alliances (World)
Rhizen Pharmaceuticals S.A. Announces Out-Licensing Agreement For TGR-1202, A Novel Next Generation PI3K-Delta Inhibitor 9/23/2014
SCHOTT Corporation And Algatechnologies Join R&D Forces 9/22/2014
MediGene AG (MDGEF.PK): New Research Collaborations And Additional Grant For Immunotherapy TABs 9/22/2014
Abcam plc (ABC.L) Licenses Novel Ceefourin Inhibitors Of Multidrug Resistance Protein 4 From Australia’s Children’s Cancer Institute 9/22/2014
Boehringer Ingelheim Corporation Will Pay Up To $600 Million For CureVac GmbH Lung Cancer Vaccine 9/19/2014
BioTie Therapies Corp.: Selincro Enters The Market In France 9/19/2014
Swedish Orphan Biovitrum Expands Haemophilia Development Portfolio - Elects To Include Potentially Longer-Acting Haemophilia A Candidate In Collaboration Agreement With Biogen Idec, Inc. (Massachusetts) (BIIB) 9/19/2014
Merck KGaA (MKGAF.PK) Wants Bids For Cancer Therapy Partners 9/18/2014
Galen Signs Exclusive Deal In Europe 9/18/2014
Protein Sciences Corporation And Diamyd Medical AB Deepen Commitment To Develop New Treatment For Diabetes 9/17/2014
3SBio Inc. (SSRX) Obtains Exclusive Licenses To Develop And Market Jenkem's PEG-Irinotecan In China 9/17/2014
NuView Life Sciences Inc. Enters Global Licensing Agreement With Otsuka Pharmaceutical Co., Ltd. 9/17/2014
Hetero Enters License Agreement With Gilead Sciences, Inc. (GILD), U.S.A. To Produce Generic Sofosbuvir For Treatment Of Chronic Hepatitis C 9/17/2014
Bay Area Startup MyoKardia Forges $200 Million Heart Disease Pact With Sanofi (France) (SAN.PA) 9/17/2014
Eli Lilly and Company (LLY) Bets $500 Million On AstraZeneca PLC (AZN)’s Alzheimer's Drug 9/17/2014
South San Francisco's Sutro Biopharma Forges $375 Million Antibody Drug Pact With Merck KGaA (MKGAF.PK) 9/17/2014
Gilead Sciences, Inc. (GILD) Says Indian Firms May Sell Generics of Hep C Drug Sovaldi 9/16/2014
Lupin Ltd. (LUPN.BO), Merck Serono Forge Emerging Markets Pact; Deal Could Add Up To 20 Drugs To Merck's Portfolio 9/16/2014
PHARNEXT And The Hereditary Neuropathy Foundation Collaborate To Increase Awareness Of Charcot-Marie-Tooth Disease 9/16/2014
Eisai Company, Ltd. (ESALY.PK) Enters Two Joint Research Agreements To Develop New Antimalarial Medicines 9/16/2014
Cellprothera And BioCardia Partner On Phase 2 EXCELLENT Trial 9/15/2014
Lupin Ltd. (LUPN.BO) May Sign $1.5 Billion Deal With Merck Serono; Lupin Stock Hits A New High 9/15/2014
Evotec AG (EVTG.F) And The Jain Foundation Expand Collaboration: Start Of Multiple Drug Screening Programmes 9/15/2014
Mylan Inc. (MYL) Signs Agreement With Gilead Sciences, Inc. (GILD) To Accelerate Access To Hepatitis C Treatments, Sovaldi® (Sofosbuvir) And Single Tablet Regimen Of Ledipasvir/Sofosbuvir, in Developing Countries 9/15/2014
BGI And The Vancouver Prostate Centre Announce Partnership To Create Joint Research Laboratory For Advancement Of Translational Cancer Research 9/12/2014
Evotec AG (EVTG.F) And CHDI, Inc. Foundation Extend Ongoing Collaboration To Fight Huntington's Disease 9/11/2014
Sophia Genetics Announces First Deal With Britain's NHS And Leading Turkish Laboratory, Expanding European Customer Base 9/11/2014
Eisai Company, Ltd. (ESALY.PK) And Kyorin Pharmaceutical Co., Ltd. Enter Into Agreement Concerning Compound Library Use For The Development Of New Antibacterial Agents 9/11/2014
Shenzhen Beike Biotechnology Co. Ltd., Altor BioScience Corporation Strike $200 Million Cancer Deal 9/10/2014
Inocucor Technologies Signs First Commercial Strategic Partnership With Axter Agroscience 9/10/2014
Medidata Solutions, Inc. And ICON Join Forces To Bring New Productivity To Capturing Patient Voice In Clinical Trials 9/10/2014
Seattle Genetics, Inc. (SGEN), Genmab A/S (GEN.CO) Partner In $211 Million Antibody-Drug Pact 9/10/2014
NeuroVive Pharmaceutical AB, Oncore Sign $150 Million Hepatitis B Pact 9/9/2014
Venus Remedies Ties It Up With Mylan Inc. (MYL) For Marketing Meropenem In Three European Countries 9/8/2014
Zhejiang Huahai And Tianjin Pharma To Form U.S.-Aimed Partnership 9/8/2014
University of Toronto Announces Strategic Collaboration With Janssen Inc. And Johnson & Johnson Innovation (JNJ) 9/8/2014
Solentim Ltd Embraces CRISPR And Other Rapid Gene-Editing Technologies With Horizon Discovery Ltd. 9/8/2014
Lee's Pharm In-licenses Second Product From Italy's Abiogen Pharma 9/8/2014
Ophthotech Corporation (OPHT) Banks $50 Million Milestone From Novartis AG (NVS) For Fovista® Pact 9/8/2014
Pfizer Inc. (PFE) Strikes Pact To Market Novartis AG (NVS)'s Respiratory Inhalers In The UK 9/5/2014
Earlier Tumour Diagnosis With Advanced Ultrasound Technology From Oxford University 9/5/2014
Hainan Sinotau In-Licenses Radiopharmaceutical From Navidea Biopharmaceuticals (NAVB) Of The U.S. 9/5/2014
Tiny Redx Pharma Signs "Transformational" Cancer Deal With AstraZeneca PLC (AZN); Financial Terms Have Not Been Disclosed 9/4/2014
Bavarian Nordic (BAVA.CO) Accelerates Ebola Vaccine Development Programs In Collaboration With The National Institutes of Health (NIH) 9/4/2014
Masters Speciality Pharma Enters Agreement With ApoPharma 9/4/2014
Navidea Biopharmaceuticals (NAVB) Enters Lymphoseek® Development And Commercialization Agreement For China 9/4/2014
Vectura Group plc (VEC.L) Release: Announcement Of Commercial Arrangement With Pfizer Inc. (PFE) UK To Promote Ultibro® Breezhaler® And Seebri® Breezhaler® In The United Kingdom 9/4/2014
BeiGene Co.,Ltd Signs China CMO Deal With Boehringer Ingelheim Corporation 9/4/2014
Ablynx (ABLYF) Signs Exclusive License Agreement With Eddingpharm (Cayman) Inc. To Develop And Commercialise Its Anti-Tnfa Nanobody In Greater China 9/2/2014
Amarillo Biosciences (AMAR) Initiates CLIA Development Of Alzheimer's Blood Diagnostic Lympro Test® At ICON Central Laboratories 9/2/2014
Advanced Biological Laboratories SA (ABL) And Mayo Medical Laboratories Announce Collaboration And Licensing Agreements 9/2/2014
CleveXel Pharma Partners With Guilin Pharmaceutical To Develop Two New Anti-Malarial Products 9/2/2014
Amerigen Pharmaceuticals And The Ningbo MENOVO Pharmaceutical Co.,LTD., Today Announced They Had Entered Into A Collaboration Agreement Regarding The Development Of Generic Pharmaceuticals, Primarily Targeting The United States Market 8/27/2014
Bavarian Nordic (BAVA.CO) Receives Order From The Canadian Government To Supply IMVAMUNE® Smallpox Vaccine 8/26/2014
A*STAR, BCA And Hitachi, Ltd. (HIT) Pilot Plant Facilitates Research For Greener Buildings 8/26/2014
Recipharm AB Forms New Collaboration With Isofol Medical AB To Exclusively Manufacture Modufolin® And Invests SEK 8 Million In The Company 8/26/2014
Luye In-Licenses China Rights To Cancer Drug From Korea's Hanmi Pharmaceutical, Co., Ltd 8/22/2014
Antitope And University College London Enter Into A Research & Licence Agreement For The Generation Of Fully Humanized Antibodies Using Antitope’s Composite Human Antibody™ Technology 8/21/2014
DESY And IBM Corporation (IBM) Develop Big Data Architecture For Science 8/21/2014
Illumina, Inc. (ILMN) Partners With AstraZeneca PLC (AZN), Johnson & Johnson (JNJ) To Create New Genetic Tests For Cancer 8/21/2014
AstraZeneca PLC (AZN), Mitsubishi Tanabe Pharma Corporation Link Up For Diabetes Research 8/20/2014
Emergent BioSolutions (EBS), MorphoSys AG Strike Prostate Cancer Pact Worth $183 Million 8/20/2014
Novartis AG (NVS), Global Alliance For TB Drug Development Link Up To Search For TB Cure 8/20/2014
Evotec AG (EVTG.F) And Medicines for Malaria Venture (MMV) Announce A Long-Term Compound Management Collaboration 8/19/2014
A*STAR And Sumitomo Mitsui Banking Corporation Ink MOU To Support Japanese R&D Collaborations With Singapore 8/19/2014
Vectura Group plc (VEC.L) Interim Management Statement 8/19/2014
Amarillo Biosciences (AMAR) Exercises Option To License Intellectual Property From University Of Miami Bascom Palmer Eye Institute For Use Of MANF In Retinal Disorders 8/15/2014
TNI BioTech Expands Partnership With Hubei Qianjiang Pharma 8/14/2014
Roche (RHHBY) Backs Out Of $600 Million Acromegaly Drug Development Deal With Chiasma Inc. 8/14/2014
TNI BioTech And Hubei Qianjiang Pharmaceutical Co., Ltd Supplemental Collaborative Agreement 8/13/2014
RedHill Biopharma Ltd. (RDHL) Acquires Option For Phase 2 Pancreatic Cancer Drug RP101 8/13/2014
Retroscreen Virology Limited Partners With ERT For Centralised ECG Services In Hvivo Challenge Studies 8/13/2014
ProSensa Holding N.V. (RNA) And CureDuchenne Strengthen Long-Term Collaboration With An Additional [Eur]5M To Advance DMD Pipeline 8/12/2014
Myelin Repair Foundation Announces Long-Term European Partnership With Hertie Foundation 8/12/2014
Protein Sciences Corporation And Liomont Announce Licensing Of Proprietary Influenza Vaccines For The Mexico Market 8/12/2014
Sanofi (France) (SAN.PA) To Pay MannKind Corporation (MNKD) Up To $925 Million For Inhaled Insulin 8/12/2014
Novartis AG (NVS), GlaxoSmithKline (GSK) Reshape Pharma With Game-Changing $14.5 Billion Deal 8/12/2014
Amarantus BioSciences, Inc. Enters Into Research Collaboration With The Buck Institute for Age Research For MANF 8/11/2014
Cancer Research Technology And Cancer Research UK Cambridge Research Institute Join Forces With Astellas Pharma Inc. (ALPMY) On Autophagy To Find New Cancer Treatments 8/8/2014
3SBio Inc. (SSRX) Signs Exclusive Patent License Agreement With DinoNa For Leukotuximab 8/8/2014
Eirgenix Signs Agreement With Taimed To Provide Development And Manufacturing Services For Taimed’s Second Generation anti-HIV mAb TMB-360 8/7/2014
Sanofi (France) (SAN.PA), Immune Design Corporation (IMDZ) Strike Food Allergy Deal Worth $168 Million+ 8/7/2014
National Institutes of Health (NIH) And Mesoblast Limited (MSB.AX) Enter Into Agreement for 120-Patient Trial In End-Stage Heart Failure 8/7/2014
Access Pharmaceuticals (ACCP) Announces European License Agreement With Norgine 8/7/2014
Pfizer Inc. (PFE), Roche (RHHBY) Join Consortium In Effort To Up Success Of Late-Phase Clinical Work 8/6/2014
Bavarian Nordic (BAVA.CO) Is The Sole Bidder For Canadian Smallpox Vaccine Supply 8/6/2014
Sanofi (France) (SAN.PA), Emcure Pharmaceuticals Limited Ink Marketing Pact For Cancer Drugs 8/6/2014
OX-MPI Project Returned To Orexo AB (ORXOF) 8/6/2014
Yabao Pharmaceuticals And Changzhou Le Sun Pharmaceuticals Ltd. Enter An Innovative Partnership To Develop Early-Stage Oncology Compound 8/6/2014
AEterna Zentaris (AEZS) And ASCEND Therapeutics, Inc. Sign Co-Promotion Agreement For U.S. Market 8/5/2014
Cesca Therapeutics And Fortis Healthcare Announce Master Collaboration Agreement 8/5/2014
Galapagos NV (GLPG.BR) Receives Milestone In Osteoarthritis Alliance With Servier 8/5/2014
BioGasol Establishes Licensed Carbofrac® Reactor Manufacture By Sweetwater Energy 8/4/2014
Amarantus BioSciences, Inc. Acquires Exclusive Option To License Alzheimer's Therapeutic IP Of Dr. Thomas Arendt From University of Leipzig 8/1/2014
Solasia Pharma K.K. Grabs Global Rights To ZIOPHARM Oncology, Inc. (ZIOP.OB)'s Zinapar For Up To $72.2 Million 8/1/2014
Evotec AG (EVTG.F) Receives First Milestones In TargetAD Collaboration 7/30/2014
AstraZeneca PLC (AZN) Taps Roche (RHHBY) For New Blood-Based Cancer Drug Tests 7/29/2014
Malaria Transmission-blocking Vaccines – ARTES Biotechnology And Burnet Announced A Development Project 7/29/2014
SDK And BIA Separations Expanding Their Co-operation 7/29/2014
Zealand Pharma  (ZEAL.CO), Boehringer Ingelheim Corporation Strike $402 Million Peptide Pact 7/28/2014
AstraZeneca PLC (AZN), QIAGEN N.V. (QGEN) Strike Lung Cancer Diagnostic Pact For Patients Suitable For Treatment With IRESSA 7/28/2014
CN Bio Innovations Marks World Hepatitis Day By Signing Research Agreement With Imperial College London 7/28/2014
Gilead Sciences, Inc. (GILD), Medicines Patent Pool Strike Deal: New Opportunity For Indian Drugmakers 7/24/2014
MorphoSys AG And Galapagos NV (GLPG.BR) Advance Joint Antibody Program In Inflammatory Diseases Into Preclinical Development 7/23/2014
China Cord Blood Corporation And Cordlife Group Limited Announce Collaboration To Aid Asia-Based Patients With Cord Blood Stem Cell Therapy 7/23/2014
Iroko Pharmaceuticals Continues To Expand Commercialization Of ZORVOLEX Ex-US 7/22/2014
ICON And University of Cambridge Collaborate To Deliver Educational Programme On Pricing & Market Access Strategy 7/22/2014
Basilea Pharmaceutica (BSLN.SW) To Launch Zevtera®/Mabelio®) (ceftobiprole medocaril) In Europe Through A Commercial Services Provider 7/21/2014
Helsinn Group And Marketing Enter Into Agreement For Marketing Rights Of Netupitant-Palonosetron Fixed-Dose Combination (NEPA) In The UK And Ireland And For Palonosetron Monotherapy In The UK 7/17/2014
The Medicines Patent Pool Signs A Record Seven New Sub-Licences To Speed The Availability Of Generic HIV Medicines To Developing Countries 7/17/2014
Eli Lilly and Company (LLY) Inks $45 Million Immunotherapy Development Deal With Immunocore Limited 7/16/2014
Harlan Laboratories, Inc. And Fluofarma Sign Strategic Collaboration Agreement 7/15/2014
Novartis AG (NVS) To Test Alzheimer's Drugs In Patients Without Symptoms 7/15/2014
LEO Pharma & Klox Technologies Strike Global Dermatology Deal 7/15/2014
Hovione And Merrion Pharmaceuticals, Inc. Announce Strategic Partnership On Use Of Merrion's GIPET Technology 7/15/2014
Geisinger Health System And Indivumed Inc. Partner For Personalized Medicine Initiative 7/15/2014
Novartis AG (NVS), Google Inc. Strike Smart Contact Lenses Pact 7/15/2014
EU Nations Join Forces Against Gilead Sciences, Inc. (GILD)'s "Exorbitant" Hepatitis C Drug 7/14/2014
Genmab A/S (GEN.CO) To Receive Milestone Payment In Duobody Platform Collaboration With Janssen Biotech Inc. (JNJ) 7/14/2014
Hemispherx Biopharma (HEB) And Bioclones, A Leading South African Biotechnology Company, Join Forces On Novel Therapeutic Cancer Vaccine 7/14/2014
NicOx SA (COX.PA) Focuses U S. Operations On National Launches Of Sjo™ And Retnagene™ And Restructures RPS® Licensing Agreement 7/10/2014
HD Biosciences Co., Ltd And Marshall University School of Medicine Reach Drug Discovery Co-Development Agreement 7/10/2014
Collaboration Between Glatt And Innopharma Labs For Real-Time In-Line Particle Characterisation In Batch / Continuous Production 7/10/2014
Lightlake Therapeutics Inc. (LLTP) Signs Agreement With Commercial Contract Manufacturer For Its Opioid Overdose Reversal Treatment 7/9/2014
AstraZeneca PLC (AZN), Max Planck Institute To Create Satellite Chemistry Unit 7/9/2014
uniQure And Medison Pharma Ltd. Sign Glybera® Distribution Agreement For Israel 7/9/2014
Protea Biosciences, Inc. And Insphero AG Enter Into Collaboration And Co-Marketing Agreement To Combine 3D Technologies 7/9/2014
Evotec AG (EVTG.F) To Collaborate With Fraunhofer In Joint Drug Discovery Programmes 7/8/2014
PHT Corporation Selects Google Inc. Nexus Android Smartphone For Logpad® System Use In Clinical Research Programs 7/8/2014
Incyte Corporation (INCY) Grabs $25 Million Milestone From Novartis AG (NVS) 7/8/2014
Compugen Ltd. (CGEN) Discloses Achievement Of Milestone In Cancer Immunotherapy Collaboration With Bayer HealthCare (BAY) 7/7/2014
Yabao Pharmaceuticals Enters Innovative Partnership With Eli Lilly and Company (LLY) To Develop Diabetes Treatment 7/7/2014
Cliniworks Forms A Strategic Alliance With Pfizer Inc. (PFE) To Develop A Population Health Management Platform With Advanced Analytics And Patient Care Capabilities 7/7/2014
Genmab A/S (GEN.CO) Reaches USD 25 Million Milestone In Daratumumab Collaboration With Janssen Biotech Inc. (JNJ) 7/7/2014
Sanofi (France) (SAN.PA) Raises Stake In Regeneron Pharmaceuticals, Inc. (REGN) 7/3/2014
UCB Group (UCBJF.PK) And Dermira Enter Into Strategic Collaboration In Dermatology To Broaden Patient Access To Cimzia® (Certolizumab Pegol) 7/3/2014
Biohit And Giraffes Pharmaceuticals Co. To Sign An Acetium Distribution Agreement 7/1/2014
First Licensing Deals For Stem Cell Company Accellta 7/1/2014
CureVac GmbH, Sanofi (France) (SAN.PA) Strike €150.5 Million+ Vaccine Pact 7/1/2014
Helsinn Group And Gen Ilac Establish A Collaboration For Anamorelin In Turkey 6/30/2014
VirtualScopics, LLC Signs An Alliance Framework Agreement With IXICO Plc; Commercial And Operational Alliance To Provide Clinical Trials Industry With Global Capabilities And A Full Range Of Therapeutic Areas And Modality Expertise 6/27/2014
Debiopharm And Nobelex Biotech Start Two Collaborations On Development Of New Antibiotics Against N. Gonorrhoeae And Enteric Species 6/26/2014
Marcomm Systems Group And Corcanna Group Strike Strategic Partnership Deal To Aid Medical Marijuana Producers 6/25/2014
Cambridge-Based Mersana Therapeutics, Inc. Strikes New Oncology Pact Worth $792 Million With Merck KGaA (MKGAF.PK) 6/25/2014
Bionomics Limited (BNO.AX) Clinches Alzheimer's Research And Funding Deal With Merck & Co., Inc. (MRK) Worth Up To $526 Million 6/24/2014
Agreement On Phase 3 Trial Protocol Of OSE Pharma's OSE-2101 From The FDA And European Medicines Agency 6/24/2014
Cook Pharmica LLC And Selexis SA Establish Customized Biologic Drug Development And Manufacturing Services Platform 6/24/2014
Ferring Pharmaceuticals, Roche (RHHBY) Partner Up To Make Personalised Infertility Treatment Possible 6/24/2014
Aurigene Discovery Technologies Limited And Orion Corporation Announce Research, Collaboration And Option Agreement For Rights To Aurigene's Epigenetics Program For Pan BET And Selective BET Bromodomain Inhibitors 6/24/2014
Sanofi (France) (SAN.PA) Throws Cancer Drug Back To Merrimack Pharmaceuticals Inc. (MACK) 6/23/2014
Servier And miRagen Therapeutics Extend Collaboration For The Research, Development And Commercialization Of Microrna-Targeting Drugs For Cardiovascular Disease 6/23/2014
China Biologic Products Announces Favorable Reduction In Value Added Tax Rate 6/23/2014
Major Drugmakers Like AstraZeneca PLC (AZN), GlaxoSmithKline (GSK). And Johnson & Johnson (JNJ) Link Up With Academia In Huge $27 Million UK Dementia Project 6/20/2014
Endocyte, Inc. (ECYT) Plummets After Merck & Co., Inc. (MRK) Backs Out Of Drug Development Deal; Stock Down -13.99% At Market Close (June 18, 2014) 6/19/2014
French Biotech Cellectis (ALCLS) Surges As Pfizer Inc. (PFE) Signs Cancer Immunotherapy Pact Worth $265 Million 6/19/2014
NicOx SA (COX.PA) And Sequenom Inc. (SQNM) Announce The Launch Of Expanded Access To Retnagene™ Test Portfolio In The U.S. 6/19/2014
Evotec AG (EVTG.F) Receives Milestone Payment As Part Of Its Discovery Alliance With Boehringer Ingelheim Corporation 6/19/2014
CEA-Leti And Akrivis Technologies To Develop Nanomedicine Platform For High Payload Targeted Drug Delivery 6/19/2014
3SBio Inc. (SSRX) Exclusively Licenses Pegsiticase (Uricase PEG-20) To Selecta Biosciences, Inc. To Develop Drug Candidate To Treat Gout 6/18/2014
uniQure And Medison Pharma Ltd. Sign Glybera Distribution Agreement For Israel 6/18/2014
Merck KGaA (MKGAF.PK) Terminates Multiple Schlerosis Drug License Agreement With Ono Pharmaceutical Company, Ltd. 6/17/2014
Sanofi (France) (SAN.PA), Medtronic, Inc. (MDT) Team Up To Develop New Diabetes Devices 6/17/2014
DrugDev Announces CFS Clinical Achieves Unprecedented $1 Billion Milestone in Global Investigator Payments 6/16/2014
Biopas And moksha8 Announce Strategic Alliance To Commercialize Specialty Pharmaceuticals Across Latin America 6/16/2014
Allenex AB Release: Three New Products Will Be Launched Globally 6/13/2014
Parion Sciences Announces Exclusive Option Agreement For The Development And Commercialization Of P-321 In Ophthalmology In Certain Asian Territories 6/12/2014
MorphoSys AG And Merck Serono Enter Strategic Immuno-Oncology Collaboration 6/12/2014
GlaxoSmithKline (GSK)'s ViiV Healthcare Joins Johnson & Johnson (JNJ)'s Janssen Research & Development To Develop Single-Pill HIV Drug 6/12/2014
AstraZeneca PLC (AZN) Beefs Up Pipeline With $232 Million Synairgen plc Asthma Deal 6/12/2014
RuiYi (formerly Anaphore) And iHuman Institute Form Collaboration To Identify Novel Antibodies Targeting GPCRs 6/11/2014
Beactica Initiates Drug Discovery Collaboration With Medivir AB (MVRBF) 6/10/2014
Biochrom Ltd. And Gilson, Inc. Sign Distribution Agreement To Deliver Automated ELISAs 6/10/2014
Isis Pharmaceuticals, Inc. (ISIS) Pockets $15 Million From AstraZeneca PLC (AZN) On ISIS-ARRx Study Initiation 6/10/2014
INVISTA And EUCODIS Bioscience To Collaborate On Development Of Enzymes For The Production Of Industrial Chemicals 6/5/2014
LALREAN, A Latin American Network Of Excellence For The Study Of Liver Diseases, Enters Into A Collaboration With Advanced Biological Laboratories SA (ABL) To Enhance Regional Understanding Of The Burden Of Hepatitis C In Latin America 6/5/2014
Cegedim SA Relationship Management Partners With Scribe Software To Enable Platform Connectivity 6/5/2014
Shuwen Biotech And DiagnoCure (CUR) Sign Exclusive License And Collaboration Agreement For Commercializing Previstage™ GCC Colorectal Cancer Staging Test In China 6/5/2014
Genmab A/S (GEN.CO) Announces Duobody And Hexabody Platform Collaboration With Undisclosed Biotechnology Company 6/4/2014
GW Pharmaceuticals Announces Agreement With New York State To Investigate Use Of CBD To Treat Medication-Resistant Epilepsies In Children 6/4/2014
arGEN-X Inks Long-Term Alliance With Shire Pharmaceuticals (SHPG) Worth $20.4 Million 6/4/2014
Foamix Announces Collaboration With National Institutes of Health (NIH) 6/3/2014
Cambridge Research Biochemicals And Key Organics Announce An Exclusive Global Supply & Marketing Agreement For Peptides 6/3/2014
Beijing Institute of Genomics And Zixin Pharmaceutical Industrial Announce China-Developed Genomics Sequencer 6/3/2014
Bayer AG (BAYZF) Pays $68 Million Upfront For Orion Corporation's Prostate Cancer Candidate ODM-201 6/2/2014
Advanced Biological Laboratories SA (ABL) And RDI Collaborate To Enhance HIV Patient Management 6/2/2014
EBD Group And Current Partnering Form Strategic Collaboration 6/2/2014
Adaptimmune Ltd., GlaxoSmithKline (GSK) Strike $350 Million Cancer Immunotherapy Pact 6/2/2014
QIAGEN N.V. (QGEN) And Eli Lilly and Company (LLY) Collaborate To Co-Develop Companion Diagnostics For Simultaneous Analysis Of Dna And Rna Biomarkers In Common Cancers 5/30/2014
NicOx SA (COX.PA): Santen, Inc. Grants EuPharmed Extension Of Exclusive Rights To Distribute Cationorm® In Italy 5/30/2014
Dako A/S (Acquired by Agilent Technologies, Inc.) (A) And U.S.-Based Merck & Co., Inc. (MRK) To Collaborate On Companion Diagnostic Test For Analysis Of Tumor PD-L1 Levels 5/30/2014
uniQure And Medison Pharma Ltd. Sign Glybera® Distribution Agreement For Israel 5/29/2014
Novozymes Biopharma Enters Agreement With A Leading Vaccine Company To Conduct Research On A Novel Subunit Vaccine Complex Based On Albumin Fusion Technology 5/29/2014
NicOx SA (COX.PA): Santen Grants Eupharmed Extension Of Exclusive Rights To Distribute Cationorm® In Italy 5/28/2014
Celerion And Korean Drug Development Fund Form Collaboration To Strengthen Early Phase Clinical Research In South Korea 5/28/2014
EffRx Signs Binosto® Distribution Agreements In Russia And Africa 5/28/2014
MacroGenics, Inc. (MGNX) And Takeda Pharmaceutical Co. Ltd. (TKPYY) Enter Strategic Alliance To Develop DART For Treatment Of Autoimmune Disorders 5/27/2014
Orient Europharma Co., Ltd. And Debiopharm Announce Their Partnership And The Launch Of Pamorelin®LA In Singapore 5/27/2014
Targos Molecular Pathology GmbH And WuXi PharmaTech Co., Ltd. To Collaborate In Clinical Biomarker Services And Pathology Training In China 5/23/2014
Wilex AG (WL6.DE) Sends Back Some Promising Drugs To UCB, Inc. (UCBJF.PK) In Effort To Stay Alive 5/22/2014
Cambridge Research Biochemicals Renews Supply Contract With The Medical Research Council For A Fourth Year 5/20/2014